{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T01:18:24Z","timestamp":1751937504666},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Prednisolone is a standard component of immunosuppressive protocols in renal transplantation (Tx) and despite standardized treatment regimens, adverse side effects are still frequent. The aim of this study was to characterize the pharmacokinetics of prednisolone and prednisone in pediatric renal transplant recipients in the first 52 weeks post Tx, to describe the relationship between prednisolone and prednisone, and to investigate a possible relationship between the development of new-onset diabetes after Tx (NODAT) and glucocorticoid exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Renal transplant recipients receiving prednisolone (n = 11, age 1\u201315 years) were included in this prospective open-label, descriptive, nonrandomized, and noninterventional study. Blood samples were drawn pre-Tx and during selected dose intervals (0, 1, 2, 4, 6, and 12 hours postdose; less frequent in children &lt;10 kg) at 1, 2, 3, 4, 12, and 52 weeks post-Tx. Concentrations of prednisolone and cortisol, their inactive keto forms, plus methylprednisolone, were measured using a validated LC-MS\/MS method. Genetic variants in the <jats:italic toggle=\"yes\">CYP3A4<\/jats:italic>, <jats:italic toggle=\"yes\">CYP3A5<\/jats:italic>, <jats:italic toggle=\"yes\">ABCB1<\/jats:italic>, and <jats:italic toggle=\"yes\">HSD11B2<\/jats:italic> genes were analyzed using real-time polymerase chain reaction and Sanger sequencing. Correlation with NODAT was investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The patients displayed considerable intra- and inter-individual variability in prednisolone exposure, with up to 5-fold differences in the area under the concentration\u2013time curve (AUC). There were up to 7-fold differences in prednisolone\/prednisone AUC ratio between patients, and patients experiencing NODAT tended to have a higher ratio (&gt;12) compared with patients without NODAT (&lt;12). Genetic variants in <jats:italic toggle=\"yes\">CYP3A5<\/jats:italic> and <jats:italic toggle=\"yes\">ABCB1<\/jats:italic> were found, but due to the limited study population causality cannot be definitive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The study suggests that a high prednisolone\/prednisone AUC ratio may be a possible risk factor for NODAT. Further studies of individualization of glucocorticoid treatment in pediatric organ Tx are warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000439","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T20:13:14Z","timestamp":1501099994000},"page":"472-482","source":"Crossref","is-referenced-by-count":6,"title":["Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients\u2014A Prospective Study"],"prefix":"10.1097","volume":"39","author":[{"given":"Ragnhild Heier","family":"Skauby","sequence":"first","affiliation":[{"name":"Medical Biochemistry and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bjerre","sequence":"additional","affiliation":[{"name":"Pediatrics, Oslo University Hospital;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingjerd","family":"S\u00e6ves","sequence":"additional","affiliation":[{"name":"Medical Biochemistry and"},{"name":"School of Pharmacy, University of Oslo; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Tore","family":"Vethe","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bremer","sequence":"additional","affiliation":[{"name":"Medical Biochemistry and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Svarstad","sequence":"additional","affiliation":[{"name":"Medical Biochemistry and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein","family":"Bergan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Oslo; and"},{"name":"Department of Pharmacology, Oslo University Hospital, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MOT.0b013e3283651b35","article-title":"Current trends in immunosuppression following organ transplantation in children","volume":"18","author":"Kim","year":"2013","journal-title":"Curr Opin Organ Transpl."},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation","volume":"51","author":"Bergmann","year":"2012","journal-title":"Clin Pharmacokinet."},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"c68","DOI":"10.1159\/000097601","article-title":"Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000","volume":"105","author":"Rees","year":"2007","journal-title":"Nephron Clin Pract."},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2011.09.011","article-title":"Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni","volume":"65","author":"Cattaneo","year":"2012","journal-title":"Pharmacol Res."},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfr374","article-title":"Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review","volume":"27","author":"Pascual","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1600-6143.2010.03047.x","article-title":"A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study","volume":"10","author":"Grenda","year":"2010","journal-title":"Am J Transplant."},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1600-6143.2012.04145.x","article-title":"Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up","volume":"12","author":"Sarwal","year":"2012","journal-title":"Am J Transplant."},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s40261-015-0334-2","article-title":"Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients","volume":"35","author":"Bergmann","year":"2015","journal-title":"Clin Drug Investig."},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-38-3-407","article-title":"Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects","volume":"38","author":"Kozower","year":"1974","journal-title":"J Clin Endocrinol Metab."},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00054725-200409000-00012","article-title":"Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein","volume":"10","author":"Dilger","year":"2004","journal-title":"Inflamm Bowel Dis."},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1023\/B:PHAM.0000003377.39548.f6","article-title":"Structural determinants of P-glycoprotein-mediated transport of glucocorticoids","volume":"20","author":"Yates","year":"2003","journal-title":"Pharm Res."},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv Drug Deliv Rev."},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0016-5085(86)90857-7","article-title":"Effect of liver function on the metabolism of prednisone and prednisolone in humans","volume":"90","author":"Renner","year":"1986","journal-title":"Gastroenterology"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","article-title":"Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids","volume":"44","author":"Czock","year":"2005","journal-title":"Clin Pharmacokinet."},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"J Endocrinol."},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev."},{"key":"R17-20230928","first-page":"75","article-title":"Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants","volume":"82","author":"Sarna","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/FTD.0b013e31825ee3f8","article-title":"The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation","volume":"34","author":"Saeves","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FTD.0b013e3182241799","article-title":"Quantification of 6 glucocorticoids in human plasma by liquid chromatography tandem mass spectrometry: method development, validation, and assessment of matrix effects","volume":"33","author":"Saeves","year":"2011","journal-title":"Ther Drug Monit."},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","article-title":"Importance of hematocrit for a tacrolimus target concentration strategy","volume":"70","author":"Storset","year":"2014","journal-title":"Eur J Clin Pharmacol."},{"issue":"suppl 1","key":"R22-20230928","first-page":"S11","article-title":"Standards of medical care in diabetes-2011","volume":"34","year":"2011","journal-title":"Diabetes Care."},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-9120(98)00084-8","article-title":"Pediatric reference ranges for creatine kinase, CKMB, Troponin I, iron, and cortisol","volume":"32","author":"Soldin","year":"1999","journal-title":"Clin Biochem."},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-197904020-00004","article-title":"Clinical pharmacokinetics of prednisone and prednisolone","volume":"4","author":"Pickup","year":"1979","journal-title":"Clin Pharmacokinet."},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00548768","article-title":"Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation","volume":"26","author":"Ost","year":"1984","journal-title":"Eur J Clin Pharmacol."},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/jcem-55-4-762","article-title":"Prednisolone clearance at steady state in man","volume":"55","author":"Legler","year":"1982","journal-title":"J Clin Endocrinol Metab."},{"key":"R27-20230928","first-page":"1622","article-title":"Renal handling of prednisolone\/prednisone: effect of steroid dose and 11 beta-hydroxysteroid dehydrogenase","volume":"9","author":"Conti","year":"1994","journal-title":"Nephrol Dial Transplant."},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00467-011-1903-0","article-title":"Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome","volume":"26","author":"Choi","year":"2011","journal-title":"Pediatr Nephrol."},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/clpt.1987.173","article-title":"Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy","volume":"42","author":"Bartoszek","year":"1987","journal-title":"Clin Pharmacol Ther."},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2125.2001.01372.x","article-title":"Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects","volume":"51","author":"Lebrun-Vignes","year":"2001","journal-title":"Br J Clin Pharmacol."},{"key":"R31-20230928","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/clpt.1991.66","article-title":"Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone","volume":"49","author":"Yamashita","year":"1991","journal-title":"Clin Pharmacol Ther."},{"key":"R32-20230928","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199019020-00003","article-title":"Clinical pharmacokinetics of prednisone and prednisolone","volume":"19","author":"Frey","year":"1990","journal-title":"Clin Pharmacokinet."},{"key":"R33-20230928","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/clpt.1989.42","article-title":"Impact of ketoconazole on the metabolism of prednisolone","volume":"45","author":"Zurcher","year":"1989","journal-title":"Clin Pharmacol Ther."},{"key":"R34-20230928","first-page":"858","article-title":"Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination","volume":"23","author":"Ludwig","year":"1989","journal-title":"Drug Intell Clin Pharm."},{"key":"R35-20230928","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.steroids.2008.04.002","article-title":"Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients","volume":"73","author":"Miura","year":"2008","journal-title":"Steroids."},{"key":"R36-20230928","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00467-012-2182-0","article-title":"Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome","volume":"27","author":"Chiou","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"R37-20230928","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet."},{"key":"R39-20230928","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/FTD.0000000000000045","article-title":"Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus","volume":"36","author":"Ionita","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R40-20230928","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2510150208","article-title":"Bioavailability and reversible metabolism of prednisone and prednisolone in man","volume":"15","author":"Garg","year":"1994","journal-title":"Biopharm Drug Dispos."},{"key":"R41-20230928","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"Am J Hypertens."},{"key":"R42-20230928","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4239\/wjd.v6.i10.1132","article-title":"Dysglycemia after renal transplantation: definition, pathogenesis, outcomes and implications for management","volume":"6","author":"Langsford","year":"2015","journal-title":"World J Diabetes"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201710000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:03:57Z","timestamp":1695863037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201710000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000439","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}